BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11010234)

  • 1. On the economic foundations of CEA. Ladies and gentlemen, take your positions!
    Brouwer WB; Koopmanschap MA
    J Health Econ; 2000 Jul; 19(4):439-59. PubMed ID: 11010234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?
    Birch S; Donaldson C
    Soc Sci Med; 2003 Mar; 56(5):1121-33. PubMed ID: 12593883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On aggregating QALYs: a comment on Dolan.
    Johannesson M
    J Health Econ; 1999 Jun; 18(3):381-6. PubMed ID: 10537901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected.
    Liljas B
    Eur J Health Econ; 2010 Feb; 11(1):5-13. PubMed ID: 19255794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implications.
    Basu A
    J Health Econ; 2020 Mar; 70():102287. PubMed ID: 31972535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drawing a veil over the measurement of social welfare--a reply to Johannesson.
    Dolan P
    J Health Econ; 1999 Jun; 18(3):387-90. PubMed ID: 10537902
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dollar is a dollar is a dollar--or is it?
    Brouwer WB; van Exel NJ; Baltussen RM; Rutten FF
    Value Health; 2006; 9(5):341-7. PubMed ID: 16961552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On individual preferences and aggregation in economic evaluation in healthcare.
    Liljas B; Lindgren B
    Pharmacoeconomics; 2001; 19(4):323-35. PubMed ID: 11383750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential to forgo social welfare gains through overrelianceon cost effectiveness/cost utility analyses in the evidence base for public health.
    Cohen DR; Patel N
    J Environ Public Health; 2009; 2009():107927. PubMed ID: 20049165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
    Culyer AJ; Chalkidou K
    Value Health; 2019 Jan; 22(1):99-103. PubMed ID: 30661640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Welfarism and extra-welfarism: a critical overview.
    Seixas BV
    Cad Saude Publica; 2017 Aug; 33(8):e00014317. PubMed ID: 28832769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological approach towards measuring the trade-off between equity and efficiency in health policy.
    Lindholm L; Rosén M; Emmelin M
    Health Policy; 1996 Mar; 35(3):205-16. PubMed ID: 10157398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of individual utility and social welfare.
    Dolan P
    J Health Econ; 1998 Jan; 17(1):39-52. PubMed ID: 10176314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.